Covidien Plans To Bring Back Recalled Duet TRS Surgical Stapling System

Covidien’s CEO says the company is trying to bring its surgical stapling system, which was recalled in 2012 after it was linked to postoperative injuries, back to market in about a year.

Covidien is planning to bring its Duet TRS surgical stapling system back to the U.S. market in about a year, CEO Joe Almeida said during the firm’s Aug. 1 fiscal 2013 third-quarter earnings call.

“We are working now with the FDA and we probably are looking into another 12 months in terms of filings...

More from Archive

More from Medtech Insight